Notable
DEXAD · Two Dexamfetamine Sulfate Formulations · ADHD and Moderate to Severe Depression
Primary completion pushed from Dec 2026 to Mar 2028
Also in this update: Trial sites expanded: 2 → 5 locations; Study completion pushed from Dec 2026 to Dec 2028
Prof. Dr. Frank BehrensPhase 2 NCT06967857 Registry history of NCT06967857 on ClinicalTrials.gov (opens the registry)